Northern Trust’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Sell |
1,095,994
-55,573
| -5% | -$189K | ﹤0.01% | 2637 |
|
|
2025
Q1 | $4.62M | Sell |
1,151,567
-36,764
| -3% | -$147K | ﹤0.01% | 2457 |
|
|
2024
Q4 | $7.71M | Buy |
1,188,331
+121,268
| +11% | +$787K | ﹤0.01% | 2274 |
|
|
2024
Q3 | $5.91M | Sell |
1,067,063
-18,324
| -2% | -$102K | ﹤0.01% | 2383 |
|
|
2024
Q2 | $6.06M | Sell |
1,085,387
-45,235
| -4% | -$252K | ﹤0.01% | 2284 |
|
|
2024
Q1 | $7.59M | Sell |
1,130,622
-60,002
| -5% | -$403K | ﹤0.01% | 2223 |
|
|
2023
Q4 | $10.9M | Buy |
1,190,624
+47,649
| +4% | +$435K | ﹤0.01% | 2005 |
|
|
2023
Q3 | $6.31M | Buy |
1,142,975
+68,327
| +6% | +$377K | ﹤0.01% | 2298 |
|
|
2023
Q2 | $9.18M | Buy |
1,074,648
+106,758
| +11% | +$912K | ﹤0.01% | 2127 |
|
|
2023
Q1 | $8.89M | Buy |
967,890
+27,943
| +3% | +$257K | ﹤0.01% | 2098 |
|
|
2022
Q4 | $9.6M | Buy |
939,947
+18,278
| +2% | +$187K | ﹤0.01% | 2041 |
|
|
2022
Q3 | $13.6M | Buy |
921,669
+93,053
| +11% | +$1.37M | ﹤0.01% | 1763 |
|
|
2022
Q2 | $8.89M | Buy |
828,616
+121,153
| +17% | +$1.3M | ﹤0.01% | 2118 |
|
|
2022
Q1 | $7.63M | Buy |
707,463
+547,658
| +343% | +$5.9M | ﹤0.01% | 2319 |
|
|
2021
Q4 | $2.61M | Buy |
159,805
+15,946
| +11% | +$260K | ﹤0.01% | 3095 |
|
|
2021
Q3 | $3.08M | Buy |
+143,859
| New | +$3.08M | ﹤0.01% | 3044 |
|